Cargando…
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352870/ https://www.ncbi.nlm.nih.gov/pubmed/30774311 http://dx.doi.org/10.2147/DDDT.S192124 |
| _version_ | 1783390931867664384 |
|---|---|
| author | Spagnuolo, Vincenzo Galli, Laura Poli, Andrea Bigoloni, Alba Fumagalli, Luca Gianotti, Nicola Nozza, Silvia Ferrari, Davide Locatelli, Massimo Lazzarin, Adriano Castagna, Antonella |
| author_facet | Spagnuolo, Vincenzo Galli, Laura Poli, Andrea Bigoloni, Alba Fumagalli, Luca Gianotti, Nicola Nozza, Silvia Ferrari, Davide Locatelli, Massimo Lazzarin, Adriano Castagna, Antonella |
| author_sort | Spagnuolo, Vincenzo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6352870 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63528702019-02-15 A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study Spagnuolo, Vincenzo Galli, Laura Poli, Andrea Bigoloni, Alba Fumagalli, Luca Gianotti, Nicola Nozza, Silvia Ferrari, Davide Locatelli, Massimo Lazzarin, Adriano Castagna, Antonella Drug Des Devel Ther Research Letter Dove Medical Press 2019-01-24 /pmc/articles/PMC6352870/ /pubmed/30774311 http://dx.doi.org/10.2147/DDDT.S192124 Text en © 2019 Spagnuolo et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Research Letter Spagnuolo, Vincenzo Galli, Laura Poli, Andrea Bigoloni, Alba Fumagalli, Luca Gianotti, Nicola Nozza, Silvia Ferrari, Davide Locatelli, Massimo Lazzarin, Adriano Castagna, Antonella A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study |
| title | A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study |
| title_full | A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study |
| title_fullStr | A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study |
| title_full_unstemmed | A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study |
| title_short | A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study |
| title_sort | nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in hiv-1-infected patients with virological failure: the dolatav study |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352870/ https://www.ncbi.nlm.nih.gov/pubmed/30774311 http://dx.doi.org/10.2147/DDDT.S192124 |
| work_keys_str_mv | AT spagnuolovincenzo anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT gallilaura anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT poliandrea anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT bigolonialba anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT fumagalliluca anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT gianottinicola anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT nozzasilvia anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT ferraridavide anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT locatellimassimo anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT lazzarinadriano anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT castagnaantonella anucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT spagnuolovincenzo nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT gallilaura nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT poliandrea nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT bigolonialba nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT fumagalliluca nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT gianottinicola nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT nozzasilvia nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT ferraridavide nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT locatellimassimo nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT lazzarinadriano nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy AT castagnaantonella nucleosidesparingregimenofdolutegravirplusritonavirboostedatazanavirinhiv1infectedpatientswithvirologicalfailurethedolatavstudy |